Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QA-Bio is a private life science tools company focused on glycan analysis products and services for the biopharmaceutical manufacturing community. Founded in 2002, the company supplies enzymes, glycan labeling kits, standards, HPLC-related products, and other reagents used to analyze glycans and glycoproteins on biotherapeutics. Its offerings are positioned for pharmaceutical research, process development, quality control, and manufacturing support rather than therapeutic drug development. QA-Bio also provides glycoanalytical services and sells globally through direct channels and regional entities in the Americas, Europe, and Asia. The company appears to be a commercial-stage analytical tools and services business rather than a drug pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QA-Bio.